Key facts
- This page summarizes Everett Cunningham's Form 4 filing for EXACT SCIENCES CORP (EXAS).
- 6 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 13 Oct 2023, 19:59.
Everett Cunningham - 11 Oct 2023 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- EXAS
- Reported as of
- 11 Oct 2023
- Net transaction value
- -$843,551
- SEC form
- 4
- Accepted by SEC
- 13 Oct 2023, 19:59:08 UTC
- Prior SEC filing
- 20 Jun 2023
- Next SEC filing
- 23 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Everett Cunningham by Mark R. Busch, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Everett Cunningham filed Form 4 for EXACT SCIENCES CORP (EXAS) on 13 Oct 2023.
Change
- Previous filing in this sequence was filed on 20 Jun 2023.
- Current net transaction value: -$843,551.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EXAS
transaction
Common Stock
Award
- Transaction value
- $21,284
- Shares
- +709
- Change %
- +3.1%
- Price
- $30.02
- Shares after
- 23,412
- Date
- 01 May 2023
- Ownership
- Direct
- Footnotes
- F1
EXAS
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +20,003
- Change %
- +85%
- Price
- $0.000000
- Shares after
- 43,415
- Date
- 11 Oct 2023
- Ownership
- Direct
- Footnotes
- F2
EXAS
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +7,501
- Change %
- +17%
- Price
- $0.000000
- Shares after
- 50,916
- Date
- 11 Oct 2023
- Ownership
- Direct
- Footnotes
- F2
EXAS
transaction
Common Stock
Sale
- Transaction value
- $864,835
- Shares
- -13,007
- Change %
- -26%
- Price
- $66.49
- Shares after
- 37,909
- Date
- 12 Oct 2023
- Ownership
- Direct
- Footnotes
- F3, F4
EXAS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 269
- Date
- 11 Oct 2023
- Ownership
- Held in 401(k) Plan
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EXAS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -20,003
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 20,004
- Date
- 11 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,003
- Exercise price
- Footnotes
- F5, F6
EXAS
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -7,501
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 7,501
- Date
- 11 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,501
- Exercise price
- Footnotes
- F5, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Represents shares of common stock purchased through Employee Stock Purchase Plan.
Footnote F2
Represents shares of common stock received upon vesting of a restricted stock unit award.
Footnote F3
Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan, entered into September 21, 2021, to pay withholding taxes due in connection with the vesting of certain restricted stock units on October 11, 2023.
Footnote F4
In addition to the shares of Common Stock reported on this Form 4, which total 38,178 shares, Mr. Cunningham also holds, in the aggregate, an additional 71,707 restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
Footnote F5
Each restricted stock unit represents a contingent right to receive one share of common stock.
Footnote F6
Represents a restricted stock unit award that partially vested on October 11, 2023. The restricted stock units vest in three equal annual installments beginning on October 11, 2022.
Footnote F7
Represents a restricted stock unit award that vests in three annual installments, with 50% vesting on October 11, 2022, 25% vesting on October 11, 2023, and 25% vesting on October 11, 2024.